BCV
PCVX icon

Banque Cantonale Vaudoise’s Vaxcyte PCVX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,184
Closed -$81K – 1043
2024
Q1 		$81K Buy
1,184
+582
+97% +$40.3K ﹤0.01% 709
2023
Q4 		$38K Buy
+602
New +$31.3K ﹤0.01% 842

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Banque Cantonale Vaudoise's PCVX Position: Q2 2024 in Review

Banque Cantonale Vaudoise sold out of Vaxcyte (PCVX) in Q2 2024, closing a stake of 1,184 shares — an estimated $81K sold.

Banque Cantonale Vaudoise first reported a position in PCVX in Q4 2023 and held it in 2 quarters. The position peaked at $81K in Q1 2024. 265 funds tracked by Wall St. Rank hold PCVX as of Q2 2024.

  • Banque Cantonale Vaudoise reported no remaining Vaxcyte position as of Q2 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,184 Vaxcyte shares in Q2 2024, an estimated $81K.
  • Banque Cantonale Vaudoise first reported a position in Vaxcyte in Q4 2023 and held it in 2 quarters.
  • Banque Cantonale Vaudoise's Vaxcyte position peaked at $81K in Q1 2024.
  • 265 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2024, filed 31 Jul 2024.